Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Immunic, Inc. is a biotechnology company focused on developing oral immunology therapies for chronic inflammatory and autoimmune diseases, primarily multiple sclerosis. Its pipeline includes small molecule drugs targeting neuroprotection, immune modulation, and gastrointestinal regeneration. The company aims to provide disease-modifying treatments with neuroprotective, anti-inflammatory, and antiviral effects, leveraging clinical trials and strategic collaborations to address high unmet medical needs in neurology and gastroenterology markets.
This description was generated via AI from an annual report. Updated about 1 year ago.